NCT01898845View on ClinicalTrials.gov

A Phase I Study of LEE011 in Asian Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Advanced Solid Tumors
Interventions
DRUG

LEE011

Trial Locations (2)

Unknown

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Chuo-ku

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY